Bleomycin-treated myoblasts undergo p21-associated cellular senescence and have severely impaired differentiation
In conclusion, bleomycin treatment provides a valid model of damage-induced senescence that was associated with elevated p21, reduced myoblast proliferation, and aberrant cell cycle kinetics, while confirming that a multi-marker approach is needed for the accurate classification of senescence within skeletal muscle.
Source: AGE - Category: Geriatrics Source Type: research
More News: Cytology | Gastroschisis Repair | Genetics | Geriatrics | Stem Cell Therapy | Stem Cells | Study